Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Exo-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
26-Nov-2020
Consolidation/Split - BD1
25-Nov-2020
Helen Fisher Steps Down from BARD1 Board
23-Nov-2020
BARD1 Gains New High-volume Customer for its hTERT Test
30-Oct-2020
Appendix 4C and Quarterly Activities Report
27-Oct-2020
Notice of Annual General Meeting/Proxy Form
19-Oct-2020
Notice of AGM ASX Listing Rule 3.13.1
23-Sep-2020
Successful BARD1 Kit Evaluation
3-Sep-2020
BARD1 Awarded BTB Funding to Develop Breast Cancer Test
31-Aug-2020
Revised Securities Trading Policy
25-Aug-2020
Appendix 4G and Corporate Governance Statement
Previous
1
2
3
4
5
Next